Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Nov 3, 2026 · Filed Nov 13, 2026
A Xbiotech director paid $143K out of pocket for Xbiotech shares.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market purchase
Code P — open-market or private purchase
~$143,409
Shares × reported transaction price
$100K–$500K
+1.7%
Purchase shares ÷ estimated pre-transaction holdings, from the filing
First purchase in 1 month
Confirmed open-market purchases by the same insider in the available history
No
Compared with 1 earlier confirmed purchase
No other insider purchases within 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
Closed at $1.99 on Nov 3, 2026, 8% above its 52-week low and 32% below its high, after a 9% drop over the previous 30 trading days
52-week range $1.85 (Oct 26, 2026) to $2.94 (Nov 11, 2025), 13% of the way up, from 251 adjusted closes. 30 trading days earlier: $2.18 on Sep 22, 2026. Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
Insider filing
Traded Oct 26 · filed 2 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider buying
First insider buy since Jun 2019Traded Oct 26 · filed 2 days later
A Xbiotech director paid $711K out of pocket for Xbiotech shares. Shares held went up 10% with this purchase.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
